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Introduction: The release of trophic factors from mesenchymal stem cells (MSCs) is critical for tissue regeneration.
A systematic investigation of the regenerative potential of trophic factors from different MSCs, however, has not
been performed. Thus, in the present study, the regenerative potential of conditioned medium (CM) from dental
pulp, bone marrow, and adipose tissue-derived CD31− side population (SP) cells from an individual source was
compared in an ectopic tooth transplantation model.
Methods: The tooth root transplantation in an ectopic site model was used for investigation of the regenerative
potential and trophic effects in vivo. Either pulp CD31− SP cell populations (1×106 cells) at the third to fourth
passage or 5 μg/ml of CM from dental pulp, bone marrow, and adipose stem cells from four different individuals
were injected into the root with collagen TE. Each root was transplanted subcutaneously in 5-week-old severe
combined immunodeficiency mice. Each root with surrounding tissue was harvested for histology on days 7, 21,
and 28 and for Western blot analysis and real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis
on day 28. Furthermore, the trophic factors responsible for the regenerative potential were identified as the
upregulated genes present in pulp CD31− SP cells when compared with the genes in both bone marrow and adipose
CD31− SP cells by using microarray analysis, real-time RT-PCR, and Western blot analysis.
Results: Transplantation of pulp CM yielded increased volume of pulp regeneration, more bromodeoxyuridine
(BrdU)-positive migrated cells, and fewer caspase 3-positive cells in the regenerated pulp compared with the others.
Pulp CM also demonstrated significantly increased cell migration, anti-apoptosis, and angiogenesis in C2C12 cells.
Higher expression of CXCL14 and MCP1 in pulp SP cells suggested candidate trophic factors. The stimulatory effects on
both migration and angiogenesis of CXCL14 and MCP1 were demonstrated in vitro. In the regenerated tissue,
BrdU-positive migrated cells expressed CXCR4 and CCR2, receptors for CXCL14 and MCP1, respectively.
Conclusions: The higher regenerative potential of pulp SP cells may be due to potent trophic factors, including
CXCL14 and MCP1, which promote migration and angiogenesis.* Correspondence: misako@ncgg.go.jp
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Mesenchymal stem cell (MSC) therapies hold great poten-
tial to treat a wide range of diseases and tissue defects, and
over 350 clinical trials have been started. The efficacy of
MSC transplantation in humans, however, has not been
well established and this due in part to an incomplete un-
derstanding of the fate of transplanted MSCs and the lack
of regulation on cell fate, especially cell migration and
therapeutic impact [1]. It is essential to understand and
regulate the fate of transplanted MSCs by exploring cell
functions and cell-cell communication in their in vivo
microenvironment (niche) for efficient regenerative therapy.
The therapeutic functions of transplanted MSCs are not
simple innate actions but rather a coordinated process in-
volving the host microenvironment [2]. MSCs are site-
regulated and secrete bioactive factors at various concentra-
tions in response to local surrounding microenvironmental
cues [3]. For example, bone marrow-derived MSCs form
islands of bone tissue inside the bone defect area, whereas
the fat content becomes significantly higher when the sur-
rounding host calvarium contains a high content of fatty
tissue. These findings indicate that cell fate decisions are
regulated by extrinsic control factors in the immediate
microenvironment [4]. Furthermore, MSCs derived from
different tissues have been compared for regenerative cap-
ability for some experimental models, including ectopic
tooth transplantation, cardiac diseases, calvarial defects, is-
chemic diseases, and cutaneous wounds, resulting in differ-
ent efficacies [5–8]. MSCs, CD31− side population (SP)
cells from the dental pulp, are enriched in stem/progenitor
cells and significantly stimulate angiogenesis/vasculogenesis
[9]. Similarly, CD31− SP cells from bone marrow exhibit
enhanced cardiomyogenic differentiation and cardiac re-
generation [10]. Pulp, bone marrow, and adipose CD31− SP
cells are able to be isolated from the same individual por-
cine mandible. Thus, we have compared the regenerative
potential of pulp CD31− SP cells with that of bone marrow
and adipose CD31− SP cells from the same individual in is-
chemic hindlimb models, ischemic cerebrum models, and
ectopic tooth transplantation models, resulting in higher
angiogenic, neurogenic, and regenerative potential [11].
These regenerated tissues were similar in quality and inde-
pendent of the origin of the MSCs. Robust matrix forma-
tion, however, was shown in the tissue regenerated with
adipose MSC transplant in ectopic tooth transplantation
model [11]. Our preliminary study showed that after ec-
topic transplantation of demineralized and trypsin-treated
teeth with injection of any type of MSCs from pulp, bone
marrow or adipose resulted in no regenerated tissue. These
results suggest that both the endogenous cells and the bio-
chemical components in the tooth have an inductive micro-
environment to regulate the transplanted MSCs.
The regeneration-promoting properties of the trans-
planted MSCs are attributed largely to secretion andrelease of trophic factors to promote tissue regeneration
rather than direct differentiation into functional mesen-
chymal cells [12]. MSCs serve as a source of various
growth factors, cytokines, chemokines, and proteinases
[13] essential to cell survival (reduced apoptosis), angio-
genesis/vasculogenesis, neurogenesis, and matrix remod-
eling [14–18]. The paracrine factors secreted by cells can
accumulate in the conditioned medium (CM). The thera-
peutic effects of MSC-CM have been reported in several
experimental models of tissue destruction, such as injuries
in liver [19–21], kidney [22], and lung [23]; ischemic heart
[24]; ischemic stroke [25]; bone defects [26]; periodontal
disease [27]; and dermal wounds [28]. The potential prop-
erties of MSC-CM in healing/regeneration promotion have
been addressed in vitro, including enhanced proliferation,
migration, anti-apoptosis, anti-inflammation, angiogenesis,
neuritogenesis, and neuroprotection [12, 21, 29–31]. In
vivo, mobilization of endogenous stem cells by MSC-CM
enhances bone regeneration [26]. The mechanisms by
which MSC-CM provide benefits for tissue regeneration,
however, are not well understood. In addition, there have
been no systematic studies on the regenerative potential of
MSC-CM from different tissues from the same individual
using the identical isolation and culture methods for each
cell source. Transplantation of teeth in ectopic sites for
pulp/dentin regeneration is an efficacious model to com-
pare the MSC-CM isolated from different tissues.
Our previous studies have demonstrated that trans-
planted pulp MSCs and CD31− SP cells do not differen-
tiate directly into endothelial cells, neuronal cells, or
host cells but have profound trophic effects on the
nearby endogenous stem/progenitor cells in the ectopic
tooth transplantation model [11]. The trophic effects of
CM from pulp CD31− SP cells are superior in vitro to
CM from bone marrow and adipose CD31− SP cells,
leading to higher angiogenic and regenerative potential
of transplanted pulp CD31− SP cells in vivo compared
with that of bone marrow and adipose CD31− SP cells
[11]. Thus, in the present study, to clarify the precise
mechanisms of MSC-CM therapeutic effects, CM derived
from porcine dental pulp, bone marrow, and adipose
CD31− SP cells from the same individual pig were evalu-
ated in vivo for their pulp/dentin regeneration potential,
promotion of vasculogenesis/angiogenesis, proliferation,
and migratory and anti-apoptotic effects on surrounding
endogenous cells. Furthermore, upregulated genes in pulp
CD31− SP cells compared with that of bone marrow and
adipose CD31− SP cells were identified as candidate
trophic factors by microarray analysis and real-time re-
verse transcription-polymerase chain reaction (RT-PCR).
The functional roles of the candidate factors and their
cognate receptors in pulp regeneration were also investi-
gated in vivo by immunohistochemistry and molecular
biological approaches and in vitro.
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All animal experiments were conducted by using the
strict guidelines of the Animal Protocol Committees
(authorization number: AGUD156) and DNA Safety Pro-
grams at both National Center for Geriatrics and Gerontol-
ogy, Research Institute and Aichi-Gakuin University.
Cell isolation and preparation of conditioned media
CD31− SP cells from pulp, bone marrow, and adipose tissue
were isolated from porcine mandible of the same individual
pig as described previously [11]. These isolated CD31− SP
cells were plated on 35-mm collagen type I-coated dishes
(AGC TECHNO GLASS CO., Shizuoka, Japan) in Dulbec-
co’s modified Eagle’s medium (DMEM) (Sigma-Aldrich, St.
Louis, MO, USA) supplemented with 10 % fetal bovine
serum (Invitrogen Corporation, Carlsbad, CA, USA). Ad-
herent cells prior to 60 % confluency were harvested by
0.02 % EDTA and re-plated at a 1:4 dilution. The culture
medium was switched to DMEM without serum at 50 %
confluency at the fourth to fifth passage of culture. The
CM from pulp, bone marrow, and adipose CD31− SP cells
were collected 24 h later, concentrated approximately 25-
fold by using ultrafiltration unit (Amicon Ultra-15 Centrifu-
gal Filter Unit) with a 3-kDa molecular weight cutoff
(Ultracel-3 membrane) (Millipore, Billerica, MA, USA),
and stored with proteinase inhibitors (Halt™ proteinase in-
hibitor cocktail EDTA-free, Thermo Scientific, Rockford,
IL, USA) at −80 °C until use. The protein concentration of
the CM was determined by BradfordUltra™ (Expedeon,
Cambridge, UK).
Model of tooth root transplantation in an ectopic site
The tooth root transplantation in an ectopic site model
was used for investigation of the regenerative potential
and trophic effects in vivo. Porcine second incisors were
extracted and their roots were cut out, 6 mm in length,
followed by enlargement, 2 mm in width and sealing of
one end with Zinc Phosphate cement (Elite Cement)
(GC, Tokyo, Japan). Either pulp CD31− SP cell populations
(1×106 cells) at the third to fourth passage or 5 μg/ml of
CM from dental pulp, bone marrow, and adipose stem
cells from four different individuals were injected into
the root with collagen TE (Nitta Gelatin, Osaka, Japan).
Each root was transplanted subcutaneously in 5-week-
old severe combined immunodeficiency (SCID) mice
(CB17, CLEA, Tokyo, Japan) (n = 26 mice). Each root
with surrounding tissue was harvested for histology on
days 7, 21, and 28 (n = 4 mice per time point) and for
Western blot analysis and real-time RT-PCR analysis
on day 28 (n = 4 mice, respectively). Tooth roots with
a phosphate-buffered saline (PBS) injection with collagen
TE were also transplanted as a control (n = 2 mice) and
were harvested on days 21 and 28 (n = 1 mouse per time
point). The tooth roots labelled with bromodeoxyuridine(BrdU) (11299964001, Roche, Basel, Switzerland) on day 3
were harvested on day 7 (n = 4 mice).
For histology, the tooth roots were fixed in 4 % parafor-
maldehyde (Nakarai Tesque, Kyoto, Japan) at 4 °C over-
night and embedded in paraffin wax (Sigma-Aldrich) after
demineralization with Kalkitox™ (Wako, Osaka, Japan).
The paraffin sections (5 μm in thickness) were stained
with hematoxylin and eosin. Four sections at 150-μm inter-
vals for four roots, each transplanted with pulp CD31− SP
cells and three different CM, were examined for relative
amounts of regenerative tissue by capturing video images
of the histological preparations under binocular micros-
copy (M 205 FA, Leica, Wetzlar, Germany). On-screen
image outlines of newly regenerated tissue and the root
canal were traced by using Leica Application Suite
software, and the ratio of the regenerated areas to the
root canal areas was calculated (n = 4 teeth). Cell dens-
ity was analyzed after counterstaining with Hoechst
33342 (1:1000) on a BZ-9000 Biorevo fluorescence
microscope (Keyence, Osaka, Japan). The numbers of
Hoechst-positive cells to the regenerated area on days
21 and 28 were calculated in three sections of each
tooth root (n = 4 teeth).
Immunohistological analyses with mouse anti-rat
RECA1 (rat endothelial cell antigen 1) (Sanbio BV, Uden,
The Netherlands) (1:500) with biotinylated horse anti-
mouse Texas Red secondary antibody (Vector Labora-
tories, Burlingame, CA, USA) (1:200) were performed to
determine the level of neovascularization. The ratio of
the area of RECA1-positive newly formed capillaries to
the regenerated area on day 28 was calculated in three
sections of each tooth root (n = 4 teeth).
In situ hybridization was performed in the regenerated
tissues on day 28 by using a marker for pulp, thyrotropin-
releasing hormone-degrading enzyme (TRH-DE), to iden-
tify pulp tissue regeneration as described previously [11].
The sections were examined by confocal laser microscopy
(TCS SP5 conventional inverted microscope, Leica), and
three-dimensional structures were reconstructed by Leica
Application Suite Advanced Fluorescence (LAS AF) soft-
ware (Leica). The expression of TRH-DE was also con-
firmed by Western blot analysis as described previously
[32] in the regenerated tissue 28 days after transplantation
of pulp CD31− SP cells and three CM (n = 4 teeth). Nor-
mal pulp tissue from the incisors of the SCID mice was
used as a positive control (n = 4 teeth). Real-time RT-PCR
analyses were further performed by using markers for
pulp tissue, Syndecan 3 and TRH-DE, in the regenerated
tissues from each of the four root conditions 28 days after
transplantation of CD31− SP cells and each CM. The
normal pulp tissue from the same animals was used as
a control (n = 4 teeth).
Odontoblastic differentiation was assessed by in situ
hybridization by using a marker for odontoblasts,
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by using a Tyramide Signal Amplification system. The
numbers of enamelysin-positive cells along the den-
tinal wall in the regenerated tissue on day 28 were
counted in three sections of each tooth (n = 4 teeth) by
LAS AF software by using confocal laser microscopy.
To examine extracellular matrix formation, three paraf-
fin sections of each root (n = 4 teeth) on day 28 were im-
munostained by using rabbit anti-aggrecan (ab9942,
abcam, Cambridge, UK) (1:500) and goat anti-rabbit Alexa
488-conjugated secondary antibody (1:200) followed by
counterstaining with Hoechst 33342. The positive area
relative to the regenerated area was analyzed by using a
BZ9000 Biorevo fluorescence microscope.
The promotion of proliferation by pulp CD31− SP cells
and by three CM was also examined by immunohistolo-
gical analyses using proliferating cell nuclear antigen
(PCNA) (1:200) antibodies and biotinylated anti-rabbit
IgG secondary antibody (Vector Laboratories) (1:200).
The sections were developed with the ABC reagent
(Vector Laboratories) by using the DAB chromogen.
After staining, captured video images of the histological
preparations were analyzed under binocular microscopy
(M 205 FA, Leica). The number of PCNA-positive cells
was counted in the surrounding tissues of the trans-
planted teeth, including adipose, fibrous, and muscle tis-
sues, and in the regenerated tissues on day 7 in three
sections of each root by LAS AF software (n = 4 teeth).
Furthermore, the migratory effect of pulp CD31− SP cells
and three CM on endogenous cells was investigated. BrdU
(150 mg/kg) was injected intraperitoneally into the sur-
rounding tissues of each tooth 3 days after transplantation
in SCID mice (n = 4 mice). These mice were transcardially
perfused with physiological saline, followed by fixation
with 4 % paraformaldehyde in 0.1 M phosphate buffer (pH
7.4) under deep anesthesia 7 days after transplantation.
The paraffin sections of the transplanted teeth with the
surrounding tissues were immunostained with mouse
anti-human BrdU antibody (11299964001, Roche) (1:1000),
followed by a goat anti-mouse Texas Red-conjugated sec-
ondary antibody (1:200) after counterstaining with Hoechst
33342. The number of BrdU-positive cells in the regener-
ated pulp areas was calculated in three sections of each
tooth (n = 4 teeth) by LAS AF software by using confocal
laser microscopy.
Immunohistological analysis was performed by using
a rabbit anti-human caspase 3 antibody (Cell Signaling
Technology Inc., Danvers, MA, USA) (1:200) with a
goat anti-rabbit Alexa 488-conjugated secondary anti-
body (ab150077, abcam) (1:200) to examine the anti-
apoptotic effects. The ratio of caspase 3-positive cells to
Hoechst 33342-positive total cells in the regenerated tis-
sue on day 7 was calculated in three sections of each
root (n = 4 teeth).Trophic effects of the conditioned media from pulp, bone
marrow, and adipose CD31− side population cells
Mouse embryonic muscle myoblast cells (C2C12) (DS
Pharma Biomedical, Osaka, Japan) were cultured in DMEM
supplemented with 10 % fetal bovine serum (FBS) for 24 h
to analyze the enhanced effect of CM of pulp, bone mar-
row, and adipose CD31− SP cells on proliferation. Then,
the medium was changed into DMEM without serum, and
each CM was added to the medium at a final concentration
of 5 μg/ml protein. Cell numbers were measured by
Tetra-color one (Seikagaku Kogyo, Tokyo, Japan).
Horizontal chemotaxis assay was performed by using
TAXIScan-FL (Effector Cell Institute, Tokyo, Japan) as
previously described [33] to examine the effect of CM
on C2C12 cell migration.
C2C12 cells were grown in DMEM for 3 days and then
incubated with 500 nM staurosporine (Sigma-Aldrich) in
DMEM supplemented with each CM at a concentration
of 5 μg/ml protein to assess effects on apoptosis by the
CM. As a control, vascular endothelial growth factor A
(VEGF-A) (Reliatech GmbH, Wolfenbüttel, Germany) at a
final concentration of 5 μg/ml was added. The cells were
harvested 8 h later, treated with both Annexin V-FITC
(Roche Diagnostics) and propidium iodide (Sigma-Al-
drich) for 15 min, and analyzed by flow cytometry.
The endothelial differentiation potential of the CM
was assessed in C2C12 cells cultured for 21 days in
DMEM containing 2 % FBS, 5 μg/ml heparin (Lonza,
Muenchensteinerstrasse, Switzerland), 5 μg/ml ascorbic
acid (Lonza), and 5 μg/ml hydrocortisone (Lonza) supple-
mented with 5 μg/ml of each CM from pulp, bone mar-
row, and adipose CD31− SP cells. Immunocytochemical
analyses were performed for anti-vascular endothelial
(VE)-cadherin/CD144 (primary antibody, 1:50) (Acris,
Herford, Germany), and the positive number of cells was
measured on a BZ-9000 Biorevo fluorescence microscope
(Keyence) after counterstaining with Hoechst 33342. In
addition, C2C12 cells were seeded on matrigel (BD Biosci-
ences, San Jose, CA, USA) in DMEM containing 2 % FBS,
5 μg/ml heparin (Lonza), 5 μg/ml ascorbic acid (Lonza),
and 5 μg/ml hydrocortisone (Lonza) supplemented with 5
μg/ml of each CM. Network formation was observed 4 h
after cultivation. The mean lengths of the networks of
cords and tube-like structures were measured under an
inverted microscope (Leica, 6000B-4, Leica Microsystems
GmbH, Wetzlar, Germany) by using Suite V3 (Leica).
Analyses of upregulated genes in pulp CD31− side
population cells
The trophic factors responsible for the regenerative po-
tential were identified as the upregulated genes present
in pulp CD31− SP cells when compared with the genes
in both bone marrow and adipose CD31− SP cells by
using microarray analysis. Biotinylated cRNAs were
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protocol from 250 ng of total RNA isolated from the
three CD31− SP cells that were obtained from the same
individual (Affymetrix Japan K.K., Tokyo, Japan) as described
previously [11]. The nine upregulated genes—chemo-
kine (C-X-C motif ) ligand 14 (CXCL14) (accession
number: AY308800), granulocyte colony-stimulating
factor (G-CSF) (accession number: NM_213842), brain-
derived neurotrophic factor (BDNF) (accession number:
NM_214259), neuropeptide Y (NPY) (accession number:
NM_001256367), interleukin 1α (IL-1α) (accession
number: NM_214029), interleukin 6 (IL-6) (accession
number: NM_214399), interleukin 8 (IL-8) (accessionTable 1 Porcine and mouse primers for real-time reverse transcriptio
Gene name Species 5′← DNA s
CXCL14 Porcine Forward ACGGGTCC
Reverse GGCGTTGTA
G-CSF Porcine Forward CTGGACTGG
Reverse CTTAGGGTA
BDNF Porcine Forward TTCAAGAGG
Reverse AGAAGAGG
NPY Porcine Forward CTCCGCCTC
Reverse CACTTCCCA
IL-1-a Porcine Forward CAAGGACA
Reverse CATCATTCA
IL-6 Porcine Forward AGCAAGGA
Reverse CAGCCTCGA
IL-8 Porcine Forward GCATTCCAC
Reverse CTTCTGCAC
IL-16 Porcine Forward TCAGCAGC
Reverse TCTCAGCTC
MCP1 Porcine Forward TCTCCAGTC
Reverse TCCAGGTGG
β-actin Porcine Forward CTCTTCCAG
Reverse ACGTCGCA
Syndecan 3 Mouse Forward TGGCTACCT
Reverse GACTCTGGA
TRH-DE Mouse Forward CCAGCAGG
Reverse CCTGTCATC
CXCR4 Mouse Forward CCATGGCTG
Reverse TCAGGAGG
CCR2 Mouse Forward ATTCTGGGC
Reverse TCACCCCAA
β-actin Mouse Forward AAGTACCCC
Reverse ATCACAATG
BDNF, Brain-derived neurotrophic factor; bp, Base pairs; CCR2, Chemokine (C-C mot
(C-X-C motif) receptor 4; G-CSF, Granulocyte colony-stimulating factor; IL, Interleukin
2); NPY, Neuropeptide Y; TRH-DE, Thyrotropin-releasing hormone-degrading enzymnumber: NM_213867), interleukin 16 (IL-16) (accession
number: NM_213751), and monocyte chemotactic pro-
tein 1 (MCP1) (accession number: NM_214214)—were
further examined by real-time RT-PCR using primers
(Table 1). The expression levels of these genes in pulp
CD31− SP cells were compared with those in both bone
marrow and adipose CD31− SP cell populations after
normalization to β-actin.
Expression of trophic factors in CD31− side population
cells analysis by Western blot analysis
Expression of the upregulated genes, MCP1 and
CXCL14 in pulp, bone marrow, and adipose CD31− SPn-polymerase chain reaction
equence→ 3′ Product size Accession number
AAGTGAAGTGC 206 bp AY308800
CCACTTGATGA
GAGGTAGTTG 97 bp NM_213842
GGGGTTCACTC
CCTGACATCGT 180 bp NM_214259
AGGCTCCAAAGG
TGATAGTCTGC 200 bp NM_001256367
TCACCACACAG
GTGTGGTGATGG 215 bp NM_214029
GGATGCAGTGG
GGTACTGGCAGA 187 bp NM_214399
CATTTCCCTTA
ACCTTTCCAC 145 bp NM_213867
CCACTTTTCC
CAAGTGTCATC 197 bp NM_213751
CGAAAGGTTG
ACCTGCTGCTA 185 bp NM_214214
CTTATGGAGTC
CCCTCCTTCCT 80 bp AJ312193
CTTCATGATCGA
TGGACACAGAG 181 bp NM_011520
GTTGGGGTCTG
CATCAACACTTA 205 bp NM_146241
ACTGCAAGTTA
ACTGGTACTTT 210 bp NM_009911
AGGGCTGGGATC
TCACTATGCTG 188 bp NM_009915
AGGTAACTGTC
ATTGAACACGG 257 bp NM_007393
CCAGTGGTACG
if) receptor 2; CXCL14, Chemokine (C-X-C motif) ligand 14; CXCR4, Chemokine
; MCP1 (CCL2), Monocyte chemotactic protein 1 (chemokine (C-C motif) ligand
e
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population was lysed in 1 × SDS sample buffer (50 mM
Tris-HCl, pH 6.8, 2 % SDS, 10 % glycerol, 6 % β-
mercaptoethanol, and protease inhibitor) and boiled at
95 °C for 5 min. Protein (5 μg) from each cell lysate
was electrophoresed and transferred onto Immobilon-P
PVDF (polyvinylidene difluoride) membranes (Millipore).
After blocking with 5 % skim milk (Wako, Osaka, Japan)
in PBS-T at room temperature for 1 h, the membranes
were first incubated with anti-CXCL14 (ab137541, abcam)
antibody at 4 °C overnight and then with anti-rabbit IgG
horseradish peroxidase (HRP)-linked secondary antibody
(Cell Signaling, Beverly, MA, USA) at 4 °C overnight. The
protein bands were detected by Luminate™ Forte Western
HRP Substrate (Millipore). Images of the protein bands
were captured by using the Light-Capture II cooled CCD
(charge-coupled device) camera system (Atto Corp.,
Tokyo, Japan). After the CXCL14 protein band was cap-
tured, the membranes were incubated in Restore™ PLUS
Western Blot Stripping Buffer (Thermo Scientific, Rock-
ford, IL, USA) at room temperature for 15 minutes to re-
move antibody and were blocked by 5 % skim milk in
PBS-T. Then the membranes were incubated with anti-
MCP1 (ab7202, abcam) antibody at 4 °C overnight and
then with anti-rabbit IgG HRP-linked secondary antibody
at 4 °C overnight. The protein bands were detected and
captured in the same way. As an internal control, the anti-
bodies were removed from membrane again in the same
way and incubated with anti-β-actin (RB-9421, NeoMar-
kers, Fremont, CA, USA) antibody and anti-rabbit IgG
HRP-linked secondary antibody. The protein band detec-
tion and capture were performed in the same way. The in-
tensity of each band was quantified by CS Analyzer
version 3.0 (Atto Corp.). Relative protein expression level
was evaluated on the basis of band intensity of CXCL14/
β-actin and MCP1/β-actin. Each piece of data of Pulp SC
was defined as 1.0.
Expression of trophic factors and their receptors in
regenerated tissues
Double-immunostaining of either CXCL14 or MCP1
with either glutamic-oxaloacetic transaminase (GOT) or
BrdU in the regenerated tissue was performed to exam-
ine the localization of CXCL14 and MCP1 in relation to
endogenous cells migrating from the surrounding tis-
sues. The sections on day 7 were incubated with either
rabbit anti-human CXCL14 (1:500) (abcam, ab137541)
or rabbit anti-human MCP1 (1:500) (abcam, ab7202) at
4 °C overnight and then incubated with a donkey anti-
rabbit Alexa 594-conjugated secondary antibody (1:200)
(abcam, ab150076) at room temperature for 30 min.
Then immunostaining for GOT (1:500) (LS Bio, LSB-24)
with donkey anti-sheep Alexa 488-conjugated secondary
antibody (abcam, ab150177) or BrdU antibody with agoat anti-mouse Alexa 488-conjugated secondary anti-
body (ab150117, abcam) (1:200) was carried out.
The localization of MCP1 with RECA1 in relation to
newly formed blood vessels was also examined. The sec-
tions on day 7 were incubated with rabbit anti-human
MCP1 at 4 °C overnight and then with a goat anti-rabbit
Alexa 488-conjugated secondary antibody (1:200) at
room temperature for 30 min, followed by immunostain-
ing for RECA1 as described above. The diameter of 100
blood vessels selected at random was measured by LAS
AF software, and the number of MCP1-positive cells in
proximity to blood vessels was calculated in three sec-
tions of each tooth root (n = 4 teeth) by confocal laser
microscopy. The mRNA expression of the receptors
CXCR4 and CCR2 in the regenerated pulp tissues on day
28 was also examined by real-time RT-PCR (Table 1).
Immunohistological and in situ hybridization analyses of
the transplanted cells
Double staining of BrdU immunostaining and in situ
hybridization of CXCR4 and CCR2 mRNA were per-
formed to examine the expression of CXCR4 and CCR2
in cells migrating from the surrounding tissues. Mouse
cDNAs for CXCR4 (210 bp) and CCR2 (188 bp) linearized
with Spe I and Nco I, respectively, were used as anti-sense
probes, and those linearized with Nco I and Spe I, respect-
ively, were used as sense probes. The probes were con-
structed after subcloning of the PCR products by using
the same primers as designed for real-time RT-PCR. Par-
affin sections (5 μm each) of the regenerated tissues were
immunostained with a mouse anti-human BrdU antibody
(1:1000) at 4 °C overnight and then incubated with a goat
anti-mouse Alexa 488-conjugated secondary antibody
(1:100) at room temperature for 30 min to identify the mi-
grated cells. Then the sections were treated with 20 μg/ml
proteinase K for 3 min and hybridized with either CXCR4
or CCR2 probes in hybridization solution at 57 °C for 16
h. After treatment with RNase buffer at a concentration of
20 μg/ml, the sections were washed in high-stringency
buffers, 2 × side scatter and 0.1 × side scatter, each for 20
min. The sections were then incubated with anti-DIG-
HRP (Enzo Biochem, New York, NY, USA) after equilibra-
tion in Tris-NaCl-blocking buffer (pH 7.5) and developed
in Rodamine Tyramide working solution (PerkinElmer,
Boston, MA, USA) for 10 min. The sections were exam-
ined by confocal laser microscopy after counterstaining
with Hoechst 33342 for 15 min. For the control sections,
all procedures were processed in the same manner, but
the primary antibodies were omitted and/or sense probes
were used. The ratio of CXCR4-positive or CCR2-positive
cells to BrdU-positive cells as determined by confocal laser
microscopy in the regenerated pulp areas was calculated
in three sections of each tooth (n = 4 teeth) by LAS AF
software.
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Horizontal chemotaxis assay was performed by using
TAXIScan-FL (Effector Cell Institute) with either mouse
embryonic muscle myoblast cells (C2C12) (DS Pharma
Biomedical) or human umbilical vein endothelial cells
(HUVECs) to examine the effect of CXCL14 and MCP1
on cell migration as previously described [33]. Each cell
fraction was placed into the single hole with which the
device was held together with a stainless steel holder,
and the following factors were placed into the contra-
hole: either 1 μl of 1 μg/ml CXCL14 (866-CX-025, R&D
Systems, Minneapolis, MN, USA), 3 ng/ml MCP1 (279-
MC-010, R&D Systems), 5 μg/ml CM of pulp CD31− SP
cells, pulp CM with anti-CXCL14 (ab137541, abcam),
pulp CM with 2.25 μg/ml anti-MCP1 (ab7202, abcam), 1
μg/ml CXCL14 with 60 μg/ml anti-CXCL14, or 3 ng/ml
MCP1 with 2.25 μg/ml anti-MCP1 (ab7202, abcam).
Endothelial differentiation potential was assessed in
HUVECs cultured for 14 days in DMEM containing 2 %
FBS, 5 μg/ml heparin (Lonza), 5 μg/ml ascorbic acid
(Lonza), and 5 μg/ml hydrocortisone (Lonza) supple-
mented with 5 μg/ml of CM of pulp CD31− SP cells, 3
ng/ml of MCP1, 3 ng/ml MCP1 with 2.25 μg/ml anti-
MCP1, or 1 μg/ml of CXCL14. Immunocytochemical
analyses were performed for anti-VE-cadherin/CD144
(primary antibody, 1:50) (Acris, Herford, Germany),
and the positive rate was measured on a BZ-9000
BIOREVO fluorescence microscope after counterstain-
ing with Hoechst 33342.
Statistical analyses
Data are reported as mean ± standard deviation. P values
were calculated by using the Student’s t test and Tukey’s
multiple comparison test in SPSS 21.0 (IBM Corporation,
Armonk, NY, USA).
Results
Pulp regeneration after tooth root transplantation
The regenerative potential of the three CM of CD31− SP
cells from dental pulp, bone marrow, and adipose tissue
was compared in a model involving tooth root trans-
plantation to ectopic sites in SCID mice. Pulp-like tissue
with well-organized vasculature was regenerated in the
tooth root 21 days after pulp CD31− SP cell transplant-
ation (Fig. 1a, e). Similar pulp-like loose connective tis-
sue was observed in transplants of the CM from pulp,
bone marrow, and adipose CD31− SP cells (Fig. 1b-d, f-
h) as in pulp CD31− SP cell transplants (Fig. 1a, e). The
numbers of cells in the regenerated tissues stained with
Hoechst 33342 was fewer in the three CM transplants
(Fig. 1k-m) compared with the pulp CD31− SP cell trans-
plants (Fig. 1j). The histomorphometric analysis con-
firmed that the regenerated pulp area and cell density in
the regenerated tissues by the three CM transplantationwere significantly lower than those of the pulp CD31−
SP cell transplantation on day 21 (Fig. 1i, n) and day 28
(data not shown). Transplantation of the CM from pulp
CD31− SP cells yielded a larger regenerated area and
higher cell density in the regenerated tissue compared
with transplantation of the CM from bone marrow and
adipose CD31− SP cells on day 21 (Fig. 1i, n3). Bone
marrow CM transplantation resulted in a significantly
larger regenerated area and greater cell density com-
pared with adipose CM transplantation on day 21 (Fig. 1i,
n). There were no significant differences in the regener-
ated area and cell density between days 21 and 28 with
pulp CD31− SP cell transplants, although all three CM
transplantations yielded a larger regenerated area and
greater cell density on day 28 compared with that ob-
served on day 21 (data not shown). These results suggest
that pulp regeneration may not be completed 21 days
after transplantation of CM, unlike pulp CD31− SP cell
transplantation, which is completed by day 21, and that
pulp CM has higher trophic effects for pulp regeneration
than other CM.
Immunostaining with an RECA1 antibody revealed the
neovascularization in the regenerated tissue by pulp
CD31− SP cell transplantation or three CM transplanta-
tions (Fig. 2a-d). Histomorphometric analysis demon-
strated that neovascularization in the pulp CM
transplants was much higher than that in both the bone
marrow and adipose CM transplants on day 28 (Fig. 2e).
TRH-DE mRNA and protein, a marker for pulp tissue,
were similarly expressed in pulp CD31− SP cell trans-
plants and in all three CM transplants in the regenerated
tissue as analyzed by both in situ hybridization and
Western blotting (Fig. 2f-j). To further confirm that the
regenerated tissues represent a pulp tissue phenotype,
mRNA expression of both Syndecan 3 and TRH-DE,
specific markers for pulp, was examined by real-time
RT-PCR analyses. Similar expression levels in the regen-
erated tissue to that in normal pulp tissue were observed
(Table 2).
Odontoblast-like spindle-shaped cells attached to the
dentinal wall, extending their processes for some dis-
tance into the dentin in the three CM transplants similar
to CD31− SP cell transplants (Fig. 2k-n). Enamelysin-
positive odontoblast-like cells, however, were fewer in
number in the bone marrow and in the adipose CM
transplants when compared with that in the pulp CM
transplants (Fig. 2o-r). Statistical analysis showed that
the number of enamelysin-positive cells was significantly
higher in the regenerated tissue in the pulp CM trans-
plants compared with that in both the bone marrow and
adipose CM transplants (Fig. 2s). Furthermore, enhanced
matrix formation was observed in both the bone marrow
and adipose CM transplants (Fig. 2t-w). Quantitative
analysis indicated that the number of aggrecan-positive
Fig. 1 Pulp regeneration after ectopic tooth root transplantation in severe combined immunodeficiency mice. a, e, j Twenty-one days after
transplantation of pulp CD31− side population (SP) cells (Pulp SCs), (b, f, k) conditioned medium (CM) from pulp CD31− SP cells (Pulp CM), (c, g, l) CM
from bone marrow CD31− SP cells (BM CM), and (d, h, m) CM from adipose CD31− SP cells (AD CM). a-h Hematoxylin-and-eosin staining. i Ratio of
regenerated area to root canal area on day 21. j-m Hoechst 33342 staining. n Cell density of the total regenerated area on day 21. Data are expressed
as mean ± standard deviation of four determinations. *P < 0.05, **P < 0.01. Col. only, collagen only
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Fig. 2 Characterization of regenerated tissue on day 28 in an ectopic tooth root transplantation model. a, f, k, o, t Transplant of pulp CD31− side
population (SP) cells (Pulp SCs). b, g, l, p, u Transplant of conditioned medium (CM) from pulp CD31− SP cells (Pulp CM). c, h, m, q, v Transplant
of CM from bone marrow CD31− SP cells (BM CM). d, i, n, r, w Transplant of CM from adipose CD31− SP cells (AD CM). a-d Immunostaining with
rat endothelial cell antigen 1 (RECA1). e Ratio of vascularization area to the total regenerated area. (f-i) In situ hybridization analysis of expression
of thyrotropin-releasing hormone-degrading enzyme (TRH-DE) as a pulp marker using an anti-sense probe reactive to both porcine and mouse
genes. j Protein expression of TRH-DE in regenerated pulp after transplantation of CM from pulp, bone marrow (BM), and adipose (AD) CD31− SP
cells. k-s Odontoblastic differentiation potential in the regenerated pulp. k-n Odontoblastic cells along with the dentinal wall. o-r In situ hybridization
analysis of enamelysin. Odontoblastic process extending into the tubular dentin (arrows). s Comparison of the numbers of enamelysin-positive cells
along the dentinal wall. t-w Immunostaining with aggrecan (green) merged with Hoechst 33342 (Blue). x Ratio of aggrecan-positive area to the total
regenerated area. Data are expressed as mean ± standard deviation of four determinations. *P < 0.05, **P < 0.01
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the pulp CM transplants compared with that in both the
bone marrow and adipose CM transplants (Fig. 2x).
Proliferation in the regenerated tissue and in the sur-
rounding tissues was examined on day 7 by immunostainingwith PCNA. PCNA-positive cells were similarly detected
in the surrounding tissues of the transplanted tooth, adi-
pose, fibrous, and muscle tissues (Fig. 3a-c) and in the re-
generated pulp (Fig. 3d). There was no significant
difference in PCNA-positive cell numbers both in the
Table 2 Relative mRNA expression of pulp markers in
regenerated tissue after transplantation of pulp CD31− side
population cells and pulp, bone marrow, and adipose
conditioned medium
Pulp Pulp BM AD
SC CM CM CM
Syndecan 3 1.3±0.3 1.1±0.2 1.2±0.3 1.2±0.2
TRH-DE 1.2±0.2 1.1±0.1 0.9±0.4 1.0±0.5
AD, Adipose; BM, Bone marrow; CM, conditioned medium; SC, Side population
cell; TRH-DE, Thyrotropin-releasing hormone-degrading enzyme
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the pulp cell transplants and the three CM transplants
(Fig. 3a-d:e), suggesting no difference in the proliferative
effect among the three CM.
The effect of CM on the migration of the endogenous
cells from the surrounding tissues was also examined on
day 7 after BrdU labeling for 4 days. Some of the cells
stained with Hoechst 33342 were BrdU-labeled in the
regenerated tissue (Fig. 3e). Pulp CM transplants yielded
a greater number of BrdU-positive cells compared with
that in both the bone marrow and adipose CM trans-
plants, and the bone marrow CM transplants resulted in
a significantly higher number of BrdU-positive cells
compared with that in the adipose CM transplants
(Fig. 3e:e), suggesting that pulp CM has the highest mi-
gratory effect among the three CM.
The anti-apoptotic activity of the CM was examined
by immunostaining with caspase 3. Significantly fewer
caspase 3-positive cells were observed in the tissue regen-
erated in the presence of pulp CD31− SP cell transplanted
cells compared with that in three CM transplants (Fig. 3f).
Pulp CM transplants yielded fewer caspase 3-positive cells
in the regenerated tissue compared with bone marrow
and adipose CM transplants (Fig. 3f:e). These results dem-
onstrated that transplantation of CM from pulp CD31− SP
cells yielded higher regenerated pulp tissue compared with
CM from bone marrow and adipose CD31− SP cells. Fur-
thermore, this higher regenerative potential of CM from
pulp CD31− SP cells may be caused by its stimulatory ef-
fect on angiogenesis, migration, and anti-apoptosis.
To confirm this hypothesis, the possible effects of CM
from pulp, bone marrow, and adipose CD31− SP cells on
regenerative potential were further examined in vitro.
The CM from the three CD31− SP cells stimulated pro-
liferation in C2C12 cells with similar efficacy (Fig. 4a).
Pulp CM had increased migratory activity and higher
anti-apoptotic activity compared with bone marrow and
adipose CM (Fig. 4b, c). Furthermore, C2C12 differenti-
ated into VE-cadherin-positive endothelial cells in the
presence of each CM (Fig. 4e-g). Pulp CM had signifi-
cantly greater stimulatory effects on the differentiation
into endothelial cells than bone marrow and adipose CM
(Fig. 4h), indicating that pulp CM had highest angiogenicpotential. These in vitro findings demonstrate consistent
results with all the in vivo effects of each CM in the ec-
topic tooth transplantation model.
Expression of upregulated trophic factors and their
receptors in the regenerated pulp tissue
The transcriptomes of the three CD31− SP cells were
compared with each other by using a cDNA microarray
analysis (Table 3). The highly upregulated genes in pulp
CD31− SP cells relative to bone marrow and adipose
CD31− SP cells included CXCL14, G-CSF, BDNF, NPY,
IL-1α, IL-6, IL-8, IL-16, and MCP1. Real-time RT-PCR
analysis for these genes further demonstrated that
CXCL14 and MCP1 were expressed at higher levels in
pulp CD31− SP cells compared with the expression in
both bone marrow and adipose CD31− SP cells (Table 4).
Higher expression of MCP1 protein was also demon-
strated in pulp CD31− SP cells compared with that in bone
marrow and adipose CD31− SP cells. Adipose CD31− SP
cells yielded a higher expression of CXCL14 protein com-
pared with that in both the pulp and bone marrow CD31−
SP cells, and the pulp CD31− SP cells resulted in a higher
expression of CXCL14 protein compared with that in
the bone marrow CD31− SP cells. There was, however,
no significant difference in expression level (Fig. 5).
These results suggest that CXCL14 and MCP1 may be
potential candidates for the prominent trophic factors
of pulp CD31− SP cells responsible for the increased re-
generated tissue.
Recent studies have demonstrated that CXCL14
and MCP1 promoted cell migration and angiogenesis/
vasculogenesis, respectively [34, 35]. Thus, localization
of CXCL14 and MCP1 related to the migrated cells and to
the newly formed vessels in the regenerated pulp tissue 7
days after transplantation of pulp CD31− SP cells was ex-
amined. CXCL14- or MCP1-positive reactivity colocalized
with GOT-positive transplanted cells (Figs. 6a and 7a) but
did not colocalize with BrdU-positive migrated cells in the
regenerated tissue after transplantation of pulp CD31− SP
cells (Figs. 6b and 7b), indicating that CXCL14 and MCP1
are secreted by the transplanted cells and not by the en-
dogenous migrated cells. Confocal laser microscopic
analysis demonstrated that MCP1-positive cells were
not co-localized to vessels but were in proximity to two
different sized vessels of approximately 40 μm and 70-
130 μm in diameter (Fig. 7g-k), suggesting the trophic
effect of MCP1 on angiogenesis, especially for arterioles
and venules (small veins).
Next, the expression of each receptor for CXCL14 and
MCP1, CXCR4 and CCR2, respectively, was examined.
The double-staining analysis by immunohistology and in
situ hybridization in the regenerated tissue on day 7
demonstrated that migrated BrdU-positive endogenous
cells expressed CXCR4 (Fig. 6c-e) at significantly higher
Fig. 3 (See legend on next page.)
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Fig. 3 The effect of conditioned medium (CM) on proliferation, migration, and anti-apoptosis in the surrounding tissues of the transplanted teeth
and the regenerated pulp. Immunostaining with proliferating cell nuclear antigen (PCNA) in adipose (AD) tissue (a), fibrous tissue (b), muscle
tissue (c), and regenerated pulp tissue (d) 7 days after transplantation. (a) Pulp CD31− side population (SP) cells, (b) CM from pulp CD31− SP cells,
(c) CM from bone marrow (BM) CD31− SP cells, and (d) CM from AD of CD31− SP cells. (e) Ratio of PCNA-positive cell numbers to the total cell
numbers in the each tissue. e Bromodeoxyuridine (BrdU) (red) merged with Hoechst 33342 (Blue) in the regenerated pulp tissue on day 7. (e)
Ratio of BrdU-positive cell numbers to the total cell numbers. f Immunostaining with caspase 3 (green) merged with Hoechst 33342 (Blue). (e)
Ratio of caspase 3-positive cell numbers to the total cell numbers of regenerated pulp. Seven days after transplantation of (a) pulp CD31− SP cells,
(b) CM from pulp CD31− SP cells, (c) CM from BM CD31− SP cells, and (d) CM from AD of CD31− SP cells. Data are expressed as mean ± standard
deviation of four determinations. *P < 0.05, **P < 0.01
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lower level in both bone marrow and adipose CM trans-
plants (Fig. 6f). On the other hand, migrated cells
expressed relatively reduced CCR2 levels in the pulp CM
transplants compared with the higher levels in both bone
marrow and adipose CM transplants (Fig. 7f). The en-
dogenous cells may migrate from the surrounding tissues
by either the CXCL14-CXCR4 axis or MCP1-CCR2 axis
with different rates among the three CM transplants. Ex-
pression of CXCR4 and CCR2 in the regenerated pulp tis-
sues was also examined by real-time RT-PCR analysis 28Fig. 4 The trophic effects of conditioned medium (CM) of pulp, bone marr
proliferative effect analyzed by using Tetra-color one® (*P < 0.01 versus 0.2
analyzed by TAXIScan-FL® (*P < 0.05, **P < 0.01, versus adipose; †P < 0.05, †
c The anti-apoptotic activities. The relative percentages of viable and apoptot
anti-apoptotic effect of pulp CD31− SP cells compared with CM from bone m
**P < 0.01, versus pulp CM). d-g The angiogenic effect compared among the
(VE)-cadherin. h Ratio of VE-cadherin-positive cell numbers to the total cell nu
three determinations. The experiments were repeated three times. Only one r
VEGF, Vascular endothelial growth factordays after transplantation of the three CM, demonstrating
significantly higher expression compared with normal
pulp tissue (Table 5). Expression of CXCR4 was signifi-
cantly higher and expression of CCR2 was significantly
lower in the pulp CM transplants compared with bone
marrow and adipose CM transplants, consistent with the
findings of higher CXCR4-positive rate (Fig. 6f) and lower
CCR2-positive cell rate in BrdU-positive cells (Fig. 7F).
Thus, these results suggest the trophic effect of CXCL14
and MCP1 on the migrated endogenous cells through
their receptors for migration and pulp regeneration.ow, and adipose CD31− side population (SP) cells in vitro. a The
% bovine serum albumin (BSA)-treated). b The migratory effect
†P < 0.01, versus bone marrow; ##P < 0.01, versus 0.2 % BSA-treated).
ic cells were analyzed by flow cytometry. Note the significantly higher
arrow and adipose CD31− SP cells (##P < 0.01, versus non-treated;
three CM analyzed by immunocytochemistry with vascular endothelial
mbers. (**P < 0.01). Data are expressed as mean ± standard deviation of
epresentative experiment is presented. AD, Adipose; BM, Bone marrow;
Table 3 Upregulated genes expressed in pulp CD31− side population cells compared with bone marrow and adipose side
population cells
Gene name Accession number Pulp SCs/BM SC Pulp SCs/AD SC
1 CXCL14 Chemokine -X-C motif ligand 14 AY308800 20 14
2 G-CSF Granulocyte colony-stimulating factor NM_213842 20 16
3 BDNF Brain-derived neurotrophic factor NM_214259 19 3.4
4 NPY Neuropeptide Y NM_001256367 6.6 8.6
5 IL-1-a Interleukin 1-a NM_214029 35 12
6 IL-6 Interleukin 6 NM_214399 2.6 3.5
7 IL-8 Interleukin 8 NM_21 3867 220 100
8 IL-16 Interleukin 16 NM_213751 12 3.5
9 MCP1 Monocyte chemotactic protein 1 NM_214214 2.3 1.8
AD, Adipose; BM, Bone marrow; SC, Side population cell
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Next, we examined the migratory activity of CXCL14
and MCP1 and the angiogenic potential of MCP1 with
the CM of pulp CD31− SP cells in vitro. The migratory
activity of CM, CXCL14, and MCP1 was significantly
higher than that of the control in C2C12 cells. There
was a significant difference in the migratory activity be-
tween CXCL14 and MCP1 (Fig. 8a:a), although there
was no significant difference between the CM and
CXCL14. The activity of either the CM or CXCL14 was
significantly reduced when incubated together with anti-
CXCL14 (Fig. 8a:b). HUVEC migration to the CM,
CXCL14, and MCP1 was also significantly higher than
that of the control, and there was no significant differ-
ence among the CM, CXCL14, and MCP1 (Fig. 8b:a).
The migratory activity of either the CM or MCP1 was
significantly reduced when incubated together with anti-
MCP1 (Fig. 8b:b). These results demonstrate the stimu-
latory effect of CXCL14 and MCP1 on cell migration, al-
though pulp CM may contain other trophic factors
which promote cell migration. The angiogenic potentialTable 4 Relative mRNA expression of the upregulated genes in
pulp CD31− side population cells compared with bone marrow
and adipose side population cells
Gene name Pulp SCs/BM SCs Pulp SCs/AD SCs
1 CXCL14 93±02** 43±02##
2 G-CSF 1.9±0.1* 1.6±0.2
3 BDNF 1.6±0.1 1.2±0.1
4 NPY 1.9±0.2* 35±0.4##
5 IL-1-a 1.3±0.1 6.7±0.2##
6 IL-6 2.1±0.2* 46±02##
7 IL-8 53±03** 1.5±0.1
8 IL-16 53±02** 13±0.3##
9 MCP1 2.1±0.1* 4.4±0.1##
*P < 0.05, **P < 0.01: pulp side population cells (SCs) versus bone marrow (BM)
SCs, ##P <0.01: pulp SCs versus adipose (AD) SCswas further demonstrated by immunostaining with VE-
cadherin on day 14 (Fig. 8c). Pulp CM and MCP1 simi-
larly induced differentiation of HUVECs into an endo-
thelial cell lineage positive for VE-cadherin. HUVECs
were, however, negatively stained with VE-cadherin in
the presence of anti-MCP1 either to pulp CM or to
MCP1. These results suggest that the angiogenic poten-
tial of pulp CM may be partly attributed to MCP1.
Discussion
MSCs from various tissues have attracted much atten-
tion for the treatment of many diseases and injuries,
including bone and cartilage disorders, cardiovascular
diseases, neuronal injury, and neurodegeneration via a
variety of secreted trophic signals [36]. The trophic fac-
tors support regenerative processes in the damaged tis-
sue, induce angiogenesis/neurogenesis, protect cells
from apoptosis, and modulate the immune system [37].
Thus, the identification of the trophic factors applicable
in regenerative medicine has recently become a subject
of intense investigation. Proteomic techniques are cur-
rently used for the identification of trophic factors [38].Fig. 5 Western blot analyses of expression of trophic factors CXCL14
and MCP1 in pulp, bone marrow (BM), and adipose (AD) CD31− side
population (SP) cells (SCs). Relative protein expression level was
evaluated on the basis of the band intensities of CXCL14/β-actin
and MCP1/β-actin. Each piece of data of Pulp SCs was defined as
1.0. CXCL14, Chemokine (C-X-C motif) ligand 14; MCP1, Monocyte
chemotactic protein 1
Fig. 6 Localization of chemokine (C-X-C motif) ligand 14 (CXCL14) and its receptor, CXCR4, related to the transplanted cells and the endogenous
migrated cells in the regenerated pulp on day 7. a, b Immunostaining of CXCL14 (red) merged with glutamic-oxaloacetic transaminase 2 (GOT2)
or bromodeoxyuridine (BrdU) (green) and Hoechst 33342 (blue) after transplantation of pulp CD31− side population (SP) cells. c-e In situ
hybridization and immunohistochemical analysis of expression of C-X-C chemokine receptor type 4 (CXCR4) (red) merged with BrdU (green) after
transplantation of conditioned media (CM) from pulp (c), bone marrow (d), and adipose CD31− SP cells (e). f Ratio of CXCR4-positive cell numbers
to BrdU-positive cell numbers in regenerated pulp tissues. Data are expressed as mean ± standard deviation of four determinations. *P < 0.05
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ever, are regulated by a complicated microenvironment
consisting of stem cell niches, the endogenous stem/pro-
genitor cells, and the biochemical and biophysical con-
tributions of the extracellular matrix in vivo. Thus, it is
essential to use an in vivo model for identification of
candidate trophic factors for potential therapeutic appli-
cations. The tooth transplantation model in an ectopic
site provides a stable microenvironment [39–41] and has
been used to compare trophic factors, such as basic
fibroblast growth factor (bFGF) and VEGF, for their re-
generative potential with dental pulp MSCs [42, 43].
Our recent morphometric comparative study using the
ectopic tooth transplantation model has demonstrated
that MSCs from dental pulp, bone marrow, and adiposetissue qualitatively share properties in pulp regeneration
but not quantitatively. The transplanted MSCs do not
directly differentiate into endothelial cells, neural cells,
or host pulp cells in the regenerated tissues but release a
variety of trophic factors [11], suggesting that the
amount of regenerated pulp tissues may depend on the
concentration of trophic factors released from the differ-
ent MSCs. Thus, in this investigation, to further clarify
the trophic effects which highly influence the regenerative
potential of MSCs, CM derived from porcine pulp, bone
marrow, and adipose CD31− SP cells from the same in-
dividual pig were compared in vitro and in vivo in the
ectopic tooth transplantation model. We found that the
CM of pulp CD31− SP cells exhibited a significantly
greater stimulatory effect on migration, anti-apoptosis,
Fig. 7 Localization of monocyte chemotactic protein 1 (MCP1) and its receptor, CCR2, related to the transplanted cells and the endogenous migrated
cells in the regenerated pulp. a, b Immunostaining of MCP1 (red) merged with glutamic-oxaloacetic transaminase 2 (GOT2) or bromodeoxyuridine
(BrdU) (green) and Hoechst 33342 (blue) 7 days after transplantation of pulp CD31− side population (SP) cells. c-e In situ hybridization and
immunohistochemical analysis of expression of CCR2 (red) merged with BrdU (green) 7 days after transplantation of conditioned media (CM)
from pulp (c), bone marrow (d), and adipose CD31− SP cells (e). f Ratio of CCR2-positive cell numbers to BrdU-positive cell numbers in the
regenerated pulp. Data are expressed as mean ± standard deviation of four determinations. *P < 0.05. g-j MCP1-positive cells (green) in proximity to
the newly formed vessels immunostained with rat endothelial cell antigen 1 (RECA1) (red) 28 days after transplantation of pulp CD31− SP cells (g), CM
of pulp (h), CM of bone marrow (i), and CM of adipose CD31− SP cells (j). Note no co-localization. k The number of MCP1-positive cells related to the
diameter of blood vessels
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Table 5 Relative mRNA expression of chemokine receptors in
regenerated pulp after transplantation of pulp CD31− side
population cells and pulp, bone marrow, and adipose
conditioned medium compared with normal pulp
Gene name Pulp SC Pulp CM BM CM AD CM
CXCR4 64±03** 6.7±0.4**,††,§ 2.8±0.7* 3.8±1.2*
CCR2 1.7±0.3 53±0.6** 112±06**,# 8.2±0.4**
*P < 0.05, **P < 0.01: versus normal pulp, ††P < 0.01: versus bone marrow (BM)
conditioned medium (CM), §P < 0.05: versus adipose (AD) CM, #P <0.05: versus
pulp CM. SC, Side population cell
Hayashi et al. Stem Cell Research & Therapy  (2015) 6:111 Page 16 of 19and angiogenesis and had little effect on cell prolifera-
tion compared with the non-pulp-derived CM in vitro.
On the other hand, transplantation of the three CM
demonstrated similar morphological features of the re-
generated pulp tissue and similar expression of a pulp
marker, TRH-DE, to transplants of pulp CD31− SP cells,
indicating pulp tissue regeneration. The BrdU-labeledFig. 8 Trophic effects of CXCL14 and MCP1 compared with conditioned m
Effect of CXCL14 and MCP1 on migration (a) and its inhibition of anti-CXCL
(b) human umbilical vein endothelial cells (HUVECs). c Angiogenic effect of
(VE)-cadherin. Relative percentages of viable and apoptotic cells in the pres
expressed as mean ± standard deviation of four determinations. *P < 0.05,
Monocyte chemotactic protein 1cells derived from the surrounding tissues were detected
in the regenerated tissues of all transplants, indicating
migration of the endogenous cells in the tooth. These
results suggested that pulp tissue may be regenerated by
endogenous host cells that migrate in response to the
microenvironment of the tooth in all CM transplants.
Transplantation of pulp CM, however, produced a greater
amount of regenerated pulp tissue and increased cell and
capillary density compared with transplantation of non-
pulp-derived CM. Thus, these results demonstrate that the
distinct regenerative potential among the three CM may be
due not to a proliferative effect but rather to migratory,
anti-apoptotic, and angiogenic effects induced by trophic
factors.
To identify candidate trophic factors responsible for the
regenerative potential of MSCs, nine upregulated genes
highly expressed in pulp CD31− SP cells identified byedium (CM) of pulp CD31− side population (SP) cells in vitro. a, b
14 (a) or anti-MCP1 (b) (b) analyzed by TAXIScan-FL in (a) C2C12 and
MCP1 analyzed by immunocytochemistry with vascular endothelial
ence of 500 nM staurosporine analyzed by flow cytometry. Data are
**P < 0.01. CXCL14, Chemokine (C-X-C motif) ligand 14; MCP1,
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PCR, resulting in identification of CXCL14, IL-6, IL-16,
MCP1, and NPY as potential mediators of the regenerative
effect of pulp-derived CM. These three genes were
expressed at significantly higher levels in pulp CD31− SP
cells compared with the levels observed in both bone mar-
row and adipose CD31− SP cells. Higher expression of
CXCL14 and MCP1 in pulp CD31− SP cells was also con-
firmed by Western blot analysis. MCP1 have been previ-
ously identified in the MSC secretome [44], but CXCL14
was not previously identified.
CXCL14 is a member of the CXC chemokine family.
The amino acid composition of CXCL14 is well conserved
among various species. CXCL14 and CXCL12 (also
known as SDF-1) are considered to be primordial or an-
cient chemokines on the basis of their sequence conserva-
tion among all classes of vertebrates and their
homeostatic roles [45]. CXCL14 specifically binds to
CXCR4 with high affinity and is representative of a mol-
ecule coevolved with the CXCL12/CXCR4 axis to modu-
late physiological processes [46]. CXCL12 and its receptor
CXCR4 have critical functions in the migration of various
types of MSCs [47, 48]. CXCL12, however, is secreted
minimally by CD31− SP cells [49]. Our study demon-
strated that the CXCL14 gene and protein were expressed
in CD31− SP cells. Mouse embryonic muscle myoblast cell
(C2C12) migration was stimulated by both pulp CM and
CXCL14, and the enhanced migration was significantly re-
duced by CXCL14 antibody, indicating that pulp CM con-
tains CXCL14 as a migration factor. In vivo CXCL14 was
expressed in the regenerated tissue in the transplanted
pulp CD31− SP cells but not in the BrdU-positive en-
dogenous cells that had migrated, clearly suggesting its
trophic effect. The ratio of CXCR4-positive cells to BrdU-
positive migrated cells in the regenerated tissue was sig-
nificantly higher in pulp CM transplants when compared
with that in bone marrow and in adipose tissue CM-
treated transplants, suggesting prominent CXCL14-
CXCR4 axis activity for endogenous cell migration in pulp
CM transplants. Differentiation of HUVECs into endothe-
lial cell lineage was not induced by CXCL14 in vitro.
Thus, the present results suggest that CXCL14 may be an
effective trophic factor which influences endogenous cell
migration, resulting in increased cell density and regener-
ation after transplantation of MSCs or the CM of MSCs.
MCP1/CCL2 is a member of the C-C chemokine family.
MCP1 is implicated in angiogenesis and promotes
HUVEC capillary-like structure formation in vitro [50–53].
MCP1 affects the angiogenic process through increased
expression of both VEGF and HIF-α (hypoxia-inducible
factor 1-alpha) and through activation of the Ets-1 tran-
scription factor, suggesting that its angiogenic proper-
ties might be mediated by secondary angiogenic factors
[51, 52]. bFGF strongly stimulates the expression ofMCP1 in mesenchymal cells but not in endothelial cells. In
addition, the MCP1-CCR2 axis plays a critical biological
role in recovery of blood flow in a murine hindlimb ische-
mic model, implicating the stimulatory function of
MCP1 in adaptive and fibroblast growth factor-2-
mediated therapeutic neovascularization [53, 54]. Se-
creted MCP1 mediates the angiogenic effect of tissue
factor by recruiting smooth muscle cells toward endothe-
lial cells and facilitates the maturation of newly formed
microvessels in matrigel plugs in vivo [55]. In this investi-
gation, higher expression of MCP1 was demonstrated in
pulp CD31− SP cells compared with that in bone marrow
and adipose CD31− SP cells in vitro. MCP1 stimulated
HUVEC migration and angiogenesis, which were inhibited
by anti-MCP1. On the other hand, MCP1 had a small
stimulatory effect on C2C12 myoblast migration. In vivo
MCP1 was expressed in the transplanted pulp CD31− SP
cells but not in the BrdU-positive endogenous cells that
had migrated into the regenerated tissue. MCP1-positive
cells were localized in proximity to both arterioles and ve-
nules (small veins). On day 7, the expression of CCR2 in
the BrdU-labeled endogenous cells that had migrated was
lower in the pulp CM transplants compared with that in
the bone marrow and adipose CM transplants. These re-
sults suggest that the MCP1/CCR2 axis might have a
regulatory role in both the migration of endothelial cells
and maturation of neovascularization.
Conclusions
Transplantation of the CM of pulp CD31− SP cells
yielded a larger volume of pulp regeneration, demon-
strating increased migration of endogenous cells from
the surrounding tissue, elevated angiogenesis, and de-
creased apoptosis in the regenerated pulp compared
with the transplants of the CM from bone marrow and
adipose CD31− SP cells. Upregulated genes, including
CXCL14 and MCP1, in pulp CD31− SP cells were com-
pared with those in bone marrow and adipose CD31− SP
cells and were identified as candidate trophic factors.
The stimulatory effects on migration and angiogenesis of
CXCL14 and MCP1 were demonstrated in vitro. In the
regenerated tissue, the migrated cells from the surround-
ing tissue expressed the receptors, CXCR4 and CCR2.
MCP1 was expressed in proximity to both arterioles and
venules. These results demonstrate that potent factors, in-
cluding CXCL14 and MCP1, may be associated with the
higher functional regenerative potential of pulp CD31− SP
cells with greater trophic effects based on migration and
angiogenesis.
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